The human papillomavirus (HPV) vaccine has been available since 2006, and physicians at The University of Kansas Cancer Center have encouraged our patients to get the vaccination. The vaccine is FDA-approved for children at age 9 and recommended for preteen boys and girls at age 11 or 12. Men and women between the ages of 27 and 45, who didn’t get the vaccination as an adolescent, can also receive it.